Overview
Hannah Fisher, PhD is a Clinical Psychologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Duke University School of Medicine. Dr. Fisher is a member of the Duke Pain Prevention and Treatment Research Program and the Duke Cancer Prevention and Control Program at the Duke Cancer Institute. Dr. Fisher completed her graduate training in clinical health psychology at the University of Miami and her clinical internship and postdoctoral fellowship at Duke University Medical Center. Her research focuses on developing, testing, and implementing behavioral sleep and symptom management interventions for patients with cancer.
Current Appointments & Affiliations
Assistant Professor of Psychiatry and Behavioral Sciences
·
2023 - Present
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences,
Psychiatry & Behavioral Sciences
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Feasibility of a Mind-Body Program for Chronic Pain: A Randomized Clinical Trial.
Journal Article JAMA Netw Open · June 2, 2025 IMPORTANCE: Increasing physical function for individuals in chronic pain is challenging. Despite the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials guidelines, no pain trial has comprehensively assessed multimodal physical funct ... Full text Link to item CiteRelationships between pain cognitions and physical function in a sample of racially diverse, sedentary individuals with chronic pain.
Journal Article Pain Pract · April 2025 BACKGROUND: Pain from musculoskeletal pain conditions is often persistent, bothersome, and negatively impacts physical function. Individuals with musculoskeletal pain report difficulty with walking and regular activities. For some, this may be related to o ... Full text Link to item CiteWeb-Based Pain Coping Skills Training (PCST) for Managing Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: Randomized Controlled Trial Protocol.
Journal Article Contemp Clin Trials · February 2025 BACKGROUND: Aromatase inhibitors (AIs) are a cornerstone of adjuvant systemic therapy for postmenopausal patients with hormone-receptor positive (HR+) breast cancer. Although AIs decrease cancer recurrence rates and improve survival rates, approximately 50 ... Full text Link to item CiteRecent Grants
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Development of a program to assess and treat distress in glaucoma patients using an automated EHR-derived AI algorithm
ResearchPsychologist · Awarded by National Eye Institute · 2024 - 2027Improving Multimodal Physical Function in Adults with Heterogeneous Chronic Pain; Multi-Site Feasibility RCT
ResearchInvestigator · Awarded by Massachusetts General Hospital · 2022 - 2025View All Grants
Education, Training & Certifications
University of Miami ·
2020
Ph.D.
University of Miami ·
2017
M.S.